Table 3. Fasting blood sugar, lipid profile, systolic and diastolic blood pressure in L-arginine and placebo groups.
| Variables | L-arginine group (n = 25) 1 | Placebo group (n = 27) 2 | P-value 4 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | After | Change | P-value | Baseline | After | Change | P-value 3 | ||
| FBS (mg/dl) | 99.28 ±
7.78 |
96.92 ±
7.86 |
-2.36 ±
2.04 |
0.001> | 99.55 ±
5.65 |
99.89 ±
5.76 |
0.33 ±
1.39 |
0.223 | 0.001 |
| TG (mg/dl) | 74.48 ±
15.91 |
71 ±
15.67 |
-2.81 ±
3.01 |
0.001> | 74.85 ±
14.39 |
74.92 ±
14.61 |
0.7 ±
2.11 |
0.857 | 0.001> |
| LDL (mg/dl) | 100.08 ±
10.46 |
98.81 ±
10.91 |
-1.28 ±
1.65 |
0.01 | 98.55 ±
10.53 |
98.63 ±
10.78 |
0.07 ±
1.57 |
0.808 | 0.04 |
| HDL (mg/dl) | 59.31 ±
7.93 |
61.06 ±
7.16 |
1.04 ±
1.46 |
0.001> | 60.11 ±
7.09 |
60.21 ±
6.85 |
0.08 ±
1.14 |
0.702 | 0.015 |
| Cholesterol (mg/dl) | 156.32 ±
17.53 |
153.96 ±
17.09 |
-2.36 ±
2.22 |
0.001> | 158.92 ±
11.88 |
159.03 ±
11.74 |
0.11 ±
1.95 |
0.769 | 0.001> |
| SBP (mmHg) | 115.41 ±
6.11 |
114.01 ±
4.78 |
-1.41 ±
3.07 |
0.032 | 107.22 ±
5.43 |
117.22 ±
4.66 |
0 ± 3.11 | 0.001 | 0.81 |
| DBP (mmHg) | 74.4 ±
6.56 |
73.01 ±
4.33 |
-1.41 ±
3.68 |
0.07 | 75.92 ±
4.16 |
75.18 ±
4.04 |
-0.74 ±
3.85 |
0.327 | 0.532 |
Data is presented as mean and standard deviation
Abbreviation: fasting blood sugar, triglyceride, low density lipoprotein, high density lipoprotein, systolic blood pressure, diastolic blood pressure
1 Received L-arginine 2000 mg per day during study
2 Received placebo 2000 mg per day during the study
3 Obtained from paired-samples t test
4 Obtained from independent-samples t test